SCHEMBL7216463

SCHEMBL7216463

Brc1cccc(Nc2ncnc3c2oc2ccccc23)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 9/20 1.00
HPGD P15428 6/20 0.74
KDM4E B2RXH2 5/20 0.74
ALDH1A1 P00352 5/20 0.74
HSD17B10 Q99714 3/20 0.74
TSHR P16473 3/20 0.74
CASP3 P42574 2/20 0.74
SENP7 Q9BQF6 2/20 0.74
TDP1 Q9NUW8 2/20 0.74
LMNA P02545 1/20 0.74
NPC1 O15118 7/20 0.72
RAB9A P51151 7/20 0.72
MEN1 O00255 5/20 0.72
KMT2A Q03164 5/20 0.72
POLB P06746 2/20 0.72
SMN1; SMN2 Q16637 5/20 0.64
GAA P10253 1/20 0.62
MAPT P10636 5/20 0.61
MAPK1 P28482 1/20 0.60
ABCG2 Q9UNQ0 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15452556 0.85 KDM4E (1.00) EGFRHPGDKDM4EALDH1A1HSD17B10
SCHEMBL15452470 0.85 MEN1 (0.98) EGFRHPGDKDM4EALDH1A1HSD17B10
SCHEMBL15426110 0.82 NPC1 (0.77) EGFRHPGDKDM4EALDH1A1HSD17B10
SCHEMBL15427152 0.77 KDM4E (0.98) EGFRHPGDKDM4EALDH1A1HSD17B10
SCHEMBL13771841 0.75 NPC1 (0.64) EGFRHPGDKDM4EALDH1A1HSD17B10
SCHEMBL15452557 0.75 NPC1 (1.00) EGFRHPGDKDM4EALDH1A1HSD17B10
SCHEMBL2992623 0.74 EGFR (1.00) EGFRABCG2
SCHEMBL12255950 0.74 ALDH1A1 (0.59) EGFRHPGDKDM4EALDH1A1HSD17B10
SCHEMBL14067425 0.74 HPGD (0.68) EGFRHPGDKDM4EALDH1A1HSD17B10
SCHEMBL5569425 0.74 EGFR (0.72) EGFRMAPK1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596726-B1 Method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof inhibit the epidermal growth factor receptor and related receptors and, in particular, their tyrosine kinase enzyme WARNER LAMBERT COMPANY 2003-07-22 US disclosed